Market report
Pharmaceutical tenders in Czechia — market report, March 2025
Pharmaceutical tenders in Czechia in March 2025: 9,718 tenders published (+12% month on month, +45% year on year), estimated at €89,662,498 in total, and 9,772 contracts awarded (+12% month on month, +44% year on year), worth €86,428,865 (awarded value). Buyers with the most tenders: Fakultní nemocnice Bulovka (2,742), Fakultní nemocnice Brno (841) and Krajská zdravotní, a.s. (729); most contracts won: ViaPharma s.r.o. (403), ROCHE s.r.o. (285) and Janssen-Cilag s.r.o. (172). On average 14.6 bids per contract; 50% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 9,718
- Contracts awarded
- 9,772
- Contract value awarded
- €86,428,865
- Bids per contract
- 14.6
The highlighted bar is March 2025. Hover a bar for its figure; the table below has every value.
| Figure | March 2025 | February 2025 | Change | March 2024 | Change |
|---|---|---|---|---|---|
| Tenders published | 9,718 | 8,674 | +12% | 6,725 | +45% |
| Estimated value | €89,662,498 | €63,733,516 | +41% | €364,123,953 | -75% |
| Buyers | 92 | 84 | +10% | 80 | +15% |
| Contracts awarded | 9,772 | 8,691 | +12% | 6,808 | +44% |
| Contract value (awarded) | €86,428,865 | €15,047,523 | +474% | €52,278,170 | +65% |
| Winners | 383 | 379 | +1% | 369 | +4% |
| Bids per contract | 14.6 | 8.5 | — | 4.1 | — |
| Single-bid contracts | 50% | 44% | — | 44% | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | ViaPharma s.r.o. | 403 |
| 2 | ROCHE s.r.o. | 285 |
| 3 | Janssen-Cilag s.r.o. | 172 |
| 4 | Amgen s.r.o. | 159 |
| 5 | Gilead Sciences s.r.o. | 148 |
| 6 | Takeda Pharmaceuticals Czech Republic s.r.o. | 143 |
| 7 | Avenier a.s. | 136 |
| 8 | Merck Sharp & Dohme s.r.o. | 131 |
| 9 | AbbVie s.r.o. | 118 |
| 10 | BAYER s.r.o. | 112 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Medicines and pharmaceuticals
Questions and answers
- How many pharmaceutical tenders were published in Czechia in March 2025?
- 9,718 (by 92 buyers); for comparison, February 2025: 8,674, March 2024: 6,725.
- Who won the most pharmaceutical tenders in Czechia in March 2025?
- By number of contracts: ViaPharma s.r.o. (403), ROCHE s.r.o. (285), Janssen-Cilag s.r.o. (172), Amgen s.r.o. (159) and Gilead Sciences s.r.o. (148); 383 companies won contracts in all.
- Which buyers published the most pharmaceutical tenders in March 2025?
- Fakultní nemocnice Bulovka (2,742), Fakultní nemocnice Brno (841), Krajská zdravotní, a.s. (729), Fakultní nemocnice Olomouc (718) and Fakultní Thomayerova nemocnice (409).
- How competitive were pharmaceutical tenders in Czechia in March 2025?
- On average 14.6 bids per contract (173 contracts with a known number of bids); 50% of contracts had a single bid.
- What were the contracts worth in March 2025?
- €86,428,865 (awarded value, 9,772 contracts); median about €110,000.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.